Datagen Technologies, a Tel Aviv, Israel-based developer of simulated, privacy-by-design visual data sets to train deep machine learning models for real-world tasks, raised $18.5m in funding.
EyeYon Medical, a Tel Aviv, Israel-based company that develops advanced technology to treat acute problems in the ophthalmic world, closed a $25m Series C funding round.
ForSight Robotics, a Yokeneam, Israel-based company developing a next-generation miniature robotic system for ophthalmic surgery, raised $10m in seed funding.
Aqua Security, a Burlington, MA- and Ramat Gan, Israel-based cloud native security company, completed a $135M Series E funding.
Optibus, a Tel Aviv, Israel-based cloud-native AI platform for planning and operating mass transportation, raised $107m in Series C funding.
Centrical, a provider of an employee-centric success platform, closed a $32m funding round.
retrain.ai, a NYC-based provider of a talent intelligence platform that uses AI and Machine Learning to help organizations upskill, retrain and place professionals in new roles, closed a $9M Series A funding round.
LinearB, a Los Angeles, CA- and Tel Aviv, Israel-based software delivery intelligence company, raised $16M in Series A funding.
Ibex Medical Analytics, a Tel Aviv, Israel-based AI-powered cancer diagnostics company, raised $38m in Series B financing.
Digital payment company PayPal Holdings, Inc. (NASDAQ: PYPL) is to acquire Curv, a provider of cloud-based infrastructure for digital asset security based in Tel Aviv, Israel.
Seebo, a Tel Aviv, Israel-based provider of a Predictive Quality and Yield Solution, extended Series B financing round, for a total of $24M.
Papaya Global, a Tel Aviv, Israel-based workforce management platform, raised $100m in Series C funding, bringing the company’s valuation across $1 billion.
Xsight Labs, a Kiryat Gat, Israel-based fabless semiconductor startup company, closed its Series D funding.
TechsoMed, a Rehovot, Israel-based developer of an AI and Algorithm powered real-time tissue damage imaging technology (BioTrace), closed a US$7M Series B equity financing round.